As with any new supplement, it is always a good idea to speak with your healthcare provider, especially if you have existing health concerns or are taking other medications
Q: Can I take this while pregnant or breastfeeding
semaglutide: clinical decision-making in the GLP-1 landscape Tirzepatide Versus Semaglutide on Weight Loss in Type 2 Diabetes Patients: A Systematic Review and Meta-Analysis of Direct Comparative Studies Tirzepatide: A Systematic Update Efficacy and safety of tirzepatide, dual GLP-1/GIP receptor agonists, in the management of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials Tirzepatide, a dual GIP/GLP-1 receptor agonist, alleviates metabolic dysfunction-associated steatotic liver disease by reducing the expression of CD36 and OBP2A
Across the program, more than 5,800 participants have been enrolled in studies spanning obesity, sleep apnea, knee osteoarthritis, cardiovascular outcomes, and weight maintenance